Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | 0.00% |
|
0.00% | +50.00% |
Valuation
Fiscal Period: June | 2019 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Capitalization 1 | 133.8 | 7.579 | 2.526 | 9.379 | - |
Enterprise Value (EV) 1 | 133.8 | 7.579 | 2.526 | 9.379 | 9.379 |
P/E ratio | - | -1 x | - | -30 x | - |
Yield | - | - | - | - | - |
Capitalization / Revenue | 11.7 x | - | 0.26 x | 0.75 x | 0.67 x |
EV / Revenue | 11.7 x | - | 0.26 x | 0.75 x | 0.67 x |
EV / EBITDA | -8.96 x | - | 4.89 x | 7.4 x | 5.48 x |
EV / FCF | - | - | - | 17.7 x | 7.47 x |
FCF Yield | - | - | - | 5.65% | 13.4% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 185,820 | 252,618 | 252,618 | 312,618 | - |
Reference price 2 | 0.7200 | 0.0300 | 0.0100 | 0.0300 | 0.0300 |
Announcement Date | 10/28/19 | 10/28/22 | 10/18/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: June | 2019 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | 11.46 | - | 9.791 | 12.44 | 13.93 |
EBITDA 1 | -14.94 | - | 0.517 | 1.268 | 1.711 |
EBIT 1 | - | - | -0.813 | -0.082 | 0.334 |
Operating Margin | - | - | -8.3% | -0.66% | 2.4% |
Earnings before Tax (EBT) 1 | - | - | - | -0.454 | 0.034 |
Net income 1 | - | -7.009 | - | -0.454 | 0.031 |
Net margin | - | - | - | -3.65% | 0.22% |
EPS 2 | - | -0.0300 | - | -0.001000 | - |
Free Cash Flow 1 | - | - | - | 0.53 | 1.255 |
FCF margin | - | - | - | 4.26% | 9.01% |
FCF Conversion (EBITDA) | - | - | - | 41.8% | 73.35% |
FCF Conversion (Net income) | - | - | - | - | 4,048.39% |
Dividend per Share | - | - | - | - | - |
Announcement Date | 10/28/19 | 10/28/22 | 10/18/23 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2023 Q3 |
---|---|
Net sales | - |
EBITDA | - |
EBIT | - |
Operating Margin | - |
Earnings before Tax (EBT) | - |
Net income 1 | -0.685 |
Net margin | - |
EPS 2 | -0.003000 |
Dividend per Share | - |
Announcement Date | 5/23/23 |
Balance Sheet Analysis
Fiscal Period: June | 2019 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt | - | - | - | - | - |
Net Cash position | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | 0.53 | 1.26 |
ROE (net income / shareholders' equity) | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | - | - | 0.1 | 0.1 |
Capex / Sales | - | - | - | 0.8% | 0.72% |
Announcement Date | 10/28/19 | 10/28/22 | 10/18/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+50.00% | 6.89M | |
+3.99% | 3.12B | |
+99.71% | 1.88B | |
+90.48% | 64.64M | |
+300.00% | 58.35M |
- Stock Market
- Equities
- DHB Stock
- Financials Delivra Health Brands Inc.